Texereau, Patrick
Hôpital Beaujon · Institut de Cancérologie de Lorraine · Centre Hospitalier Régional et Universitaire de Nancy · Institut Paoli-Calmettes · Centre Antoine Lacassagne · Université Paris Diderot · Institut Strauss · Université de Lorraine
3 papers on CoChat
Most cited papers
- Verified
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Conroy, T., Hammel, P., Hebbar, M., Ben Abdelghani, M., Wei, A. C., Raoul, J.-L., Choné, L., Francois, E., Artru, P., Biagi, J. J., et al. (2018) · New England Journal of Medicine
Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment
Cited by 2,874
- Verified
Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings
Kubicka, S., Greil, R., André, T., Bennouna, J., Sastre, J., Van Cutsem, E., von Moos, R., Österlund, P., Reyes-Rivera, I., Müller, T., et al. (2013) · Annals of Oncology
Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments
Cited by 104
- Verified
Bevacizumab Maintenance Versus No Maintenance During Chemotherapy-Free Intervals in Metastatic Colorectal Cancer: A Randomized Phase III Trial (PRODIGE 9)
Aparicio, T., Ghiringhelli, F., Boige, V., Le Malicot, K., Taieb, J., Bouché, O., Phelip, J.-M., François, E., Borel, C., Faroux, R., et al. (2018) · Journal of Clinical Oncology
Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments
Cited by 91
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free